EU-Funded Project by Bio-Sourcing, Ciloa, and Intract Pharma Targets Inflammatory Diseases

  AB-BIOBETTER, led by Bio-Sourcing, to pioneer development of new oral formulation of adalimumab for inflammatory bowel diseases; offering patient...

May 28, 2024 | Tuesday | News
Helsinn Group and Angelini Pharma Renew Distribution Agreement for AULIN® and MESULID® in Eastern Europe

Helsinn Group (“Helsinn”), a global pharmaceutical company with a track record of over forty-five years of commercial execution and a strong ...

May 28, 2024 | Tuesday | News
HealthTech Bioactives Partners with Abolis Biotechnologies to Revolutionize Polyphenol Production

HealthTech Bioactives (HTBA) the leading innovator in polyphenol and vitamin B12 solutions for human and animal health and nutrition, is pleased to annou...

May 27, 2024 | Monday | News
Novartis' Atrasentan Demonstrates Significant Reduction in Proteinuria, Offering Hope for Improved Management of IgA Nephropathy

  The ALIGN study, focusing on atrasentan, an investigational oral selective endothelin A (ETA) receptor antagonist, revealed a remarkable 36.1% redu...

May 27, 2024 | Monday | News
FDA Grants Priority Review to Sarclisa for Transplant-Ineligible Multiple Myeloma Treatment

  Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma FDA Priority Review gran...

May 27, 2024 | Monday | News
Sandoz's Wyost® and Jubbonti® Gain EC Approval as Biosimilar Versions of Xgeva® and Prolia®

Wyost® (denosumab) and Jubbonti® (denosumab) approved by EC for all indications of denosumab reference medicines Xgeva® and Prolia® EC a...

May 22, 2024 | Wednesday | News
Roche and Amgen's New Lp(a) Test Receives FDA Breakthrough Device Designation

Approximately one in five people worldwide have elevated Lp(a) levels, putting them at increased risk of cardiovascular diseases including myocardial inf...

May 22, 2024 | Wednesday | News
Sartorius Expands Collaboration with NVIDIA to Accelerate Development of Advanced Therapies Through AI Integration

Exploring advanced technologies to help bring novel therapies to patients faster Sartorius to leverage NVIDIA solutions used in live-cell imaging platfo...

May 16, 2024 | Thursday | News
BenevolentAI & AstraZeneca Unveil Novel Heart Failure Target

BenevolentAI (“BenevolentAI” or the “Company”) (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma ...

May 15, 2024 | Wednesday | News
Sanofi and Novavax announce co-exclusive licensing agreement to co-commercialize COVID-19 vaccine

  Agreement provides patients with broader access to a protein-based non-mRNA adjuvanted COVID-19 vaccine through combined commercial strength, fro...

May 10, 2024 | Friday | News
German Court Invalidates Patent in NanoString vs. 10x Genomics Case

Bruker Corporation announced that the German Federal Patent Court has ruled in favor of NanoString Technologies Germany GmbH by invalidating European ...

May 08, 2024 | Wednesday | News
QIAGEN and FBI Join Forces to Pioneer Digital PCR Assay for QIAcuity in Forensic Applications

QIAGEN announced a cooperative research and development agreement (CRADA) with the U.S. Federal Bureau of Investigation (FBI) to develop a novel test for i...

May 08, 2024 | Wednesday | News
Selvita S.A. Completes Acquisition of PozLab, Expanding Its Footprint in Pharmaceutical Manufacturing

Selvita S.A. announced  completion of a strategic transaction in which it has acquired 100% of shares in PozLab. The closing of the transaction comes ...

May 07, 2024 | Tuesday | News
Thermo Fisher Scientific Welcomes Historic Czech Delegation, Strengthening International Ties in Science and Trade

Thermo Fisher Scientific, the world leader in serving science, was proud to welcome Jozef Sikela, Minister of Industry and Trade of the Czech Republic, alo...

May 03, 2024 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close